0R9T.LSE Equasens

Healthcare Commercial Services & Supplies London Exchange
38.83 EUR
Close of Nov 3, 2026
25.80 43.34
Market cap
EUR 581M
P/E
10.5x
P/B
-
ROE
30.4%
Dividend yield
2.60%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is 0R9T.LSE undervalued?

Graham number

The Graham number of Equasens cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Equasens fundamental analysis

No fundamental analysis for Equasens yet.

Equasens stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Equasens

Equasens Société anonyme provides healthcare IT solutions in France, Italy, Belgium, Germany, the United Kingdom, and internationally. The company operates through Sales of Configurations and Hardware, Maintenance Services and Subscriptions, and Software and Services segments. The company engages in publishing and distribution of pharmacy, practice, management software and related offerings for pharmacies, medical-social establishments, doctors, and medical auxiliaries; dist…

Full company profile